| Billy M Anderson, LICSW LADC | |
|
22 Wilson Ave Ne, 209, Saint Cloud, MN 56304-0440 | |
| (320) 259-7706 | |
| (320) 251-4590 |
| Full Name | Billy M Anderson |
|---|---|
| Gender | Male |
| Speciality | Social Worker |
| Location | 22 Wilson Ave Ne, Saint Cloud, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033286414 | NPI | - | NPPES |
| 347720700 | Other | MN | MEDICAL ASSISTANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 300215 (Minnesota) | Secondary |
| 104100000X | Social Worker | 12688 (Minnesota) | Primary |
| Entity Name | Hennepin County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780790345 PECOS PAC ID: 7911892849 Enrollment ID: O20040218001012 |
News Archive
The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.
The men who suffered horrendous reactions during a drug trial in the UK could well be facing developing cancer and other fatal diseases as a result of being poisoned in the test, and are at risk of an early death.
A team of researchers from the University of Geneva (UNIGE) has been involved in a thorough genetic investigation based on the case of a child suffering from the Nivelon-Nivelon-Mabille Syndrome, a complex condition characterised mainly by a sexual development disorder.
› Verified 1 days ago
| Entity Name | Harvodes Bereavement And Loss Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053569798 PECOS PAC ID: 0042697559 Enrollment ID: O20220520002092 |
News Archive
The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.
The men who suffered horrendous reactions during a drug trial in the UK could well be facing developing cancer and other fatal diseases as a result of being poisoned in the test, and are at risk of an early death.
A team of researchers from the University of Geneva (UNIGE) has been involved in a thorough genetic investigation based on the case of a child suffering from the Nivelon-Nivelon-Mabille Syndrome, a complex condition characterised mainly by a sexual development disorder.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Billy M Anderson, LICSW LADC 22 Wilson Ave Ne, 209, Saint Cloud, MN 56304-0440 Ph: (320) 259-7706 | Billy M Anderson, LICSW LADC 22 Wilson Ave Ne, 209, Saint Cloud, MN 56304-0440 Ph: (320) 259-7706 |
News Archive
The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.
The men who suffered horrendous reactions during a drug trial in the UK could well be facing developing cancer and other fatal diseases as a result of being poisoned in the test, and are at risk of an early death.
A team of researchers from the University of Geneva (UNIGE) has been involved in a thorough genetic investigation based on the case of a child suffering from the Nivelon-Nivelon-Mabille Syndrome, a complex condition characterised mainly by a sexual development disorder.
› Verified 1 days ago